Verkazia will offer treatment option for vernal keratoconjunctivitis

In June 2021, Verkazia was approved for the treatment of vernal keratoconjunctivitis in children and adults.
OSN Pediatrics/Strabismus Board Members discussed the potential of Verkazia (cyclosporine ophthalmic emulsion 0.1%, Santen) and other treatments for vernal keratoconjunctivitis.
Robert S. Gold, MD: How common is vernal keratoconjunctivitis (VKC)? What are your thoughts on Verkazia as a treatment and other alternative treatments?
Erin D. Stahl, MD: I think Verkazia is great. It is an increased dose of cyclosporine over something like Restasis (cyclosporine ophthalmic emulsion 0.05%,

In June 2021, Verkazia was approved for the treatment of vernal keratoconjunctivitis in children and adults.
OSN Pediatrics/Strabismus Board Members discussed the potential of Verkazia (cyclosporine ophthalmic emulsion 0.1%, Santen) and other treatments for vernal keratoconjunctivitis.
Robert S. Gold, MD: How common is vernal keratoconjunctivitis (VKC)? What are your thoughts on Verkazia as a treatment and other alternative treatments?
Erin D. Stahl, MD: I think Verkazia is great. It is an increased dose of cyclosporine over something like Restasis (cyclosporine ophthalmic emulsion 0.05%,